Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.
(Q45093247)
scientific article published on 6 September 2011
scientific article published on 6 September 2011
Language:
Current Data About
Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.